Research output per year
Research output per year
- 1 - 50 out of 75 results
Search results
-
2025
Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses
Averbuch, I., Bareket-Samish, A., Goldstein, D. A., Eizenstein, S., Markel, G., Rosenbaum, E., Limon, D., Bomze, D., Ludmir, E. B. & Meirson, T., 1 Jun 2025, In: International Journal of Radiation Oncology Biology Physics. 122, 2, p. 224-233 10 p.Research output: Contribution to journal › Article › peer-review
-
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Meirson, T., Ofer, J., Zimhony-Nissim, N., Bareket-Samish, A., Markel, G., Neiman, V., Cherny, N., Goldstein, D. A., Gyawali, B., Tannock, I. & Rosenbaum, E., 22 Jan 2025, In: JAMA network open. 8, 1, e2455630.Research output: Contribution to journal › Article › peer-review
Open Access -
Reducing pERKs to Break “RAS”istance to Sotorasib
Gray, S. G., O'Connor, D., Mutti, L. & Meirson, T., Mar 2025, In: Journal of Thoracic Oncology. 20, 3, p. 259-261 3 p.Research output: Contribution to journal › Editorial
-
Representation of the Middle East a nd North African Region in Oncology Clinical Trials
Taha, T., Meirson, T. & Waldhorn, I., 2025, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
-
2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time
Averbuch, I., Moore, A., Ludmir, E. B., Markel, G. & Meirson, T., 29 Jun 2024, In: British Journal of Cancer. 130, 12, p. 1929-1935 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
Hsu, E. J., Lin, T. A., Dabush, D. R., McCaw, Z., Koong, A., Lin, C., Abi Jaoude, J., Patel, R., Kouzy, R., El Alam, M. B., Noticewala, S., Yang, Y., Sherry, A. D., Fuller, C. D., Thomas, C. R., Tang, C., Msaouel, P., Das, P., Huang, B. & Tian, L. & 4 others, , 1 Jun 2024, In: Journal of the National Cancer Institute. 116, 6, p. 990-994 5 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma
Gray, S. G., Meirson, T. & Mutti, L., Apr 2024, In: Journal of Thoracic Oncology. 19, 4, p. 541-546 6 p.Research output: Contribution to journal › Editorial
Open Access7 Scopus citations -
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020
Sherry, A. D., Hahn, A. W., Mccaw, Z. R., Abi Jaoude, J., Kouzy, R., Lin, T. A., Minsky, B., Fuller, C. D., Meirson, T., Msaouel, P. & Ludmir, E. B., 28 Mar 2024, In: JAMA network open. 7, 3, p. E243379Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer
Gray, S. G., Mutti, L. & Meirson, T., Aug 2024, In: Journal of Thoracic Oncology. 19, 8, p. 1125-1127 3 p.Research output: Contribution to journal › Editorial
-
Peptriever: a Bi-Encoder approach for large-scale protein–peptide binding search
Gurvich, R., Markel, G., Tanoli, Z. & Meirson, T., 1 May 2024, In: Bioinformatics. 40, 5, btae303.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation
Lin, T. A., McCaw, Z. R., Koong, A., Lin, C., Jaoude, J. A., Patel, R., Kouzy, R., El Alam, M. B., Sherry, A. D., Noticewala, S. S., Fuller, C. D., Thomas, C. R., Sun, R., Lee, J. J., Lin, R., Yuan, Y., Shyr, Y., Meirson, T. & Ludmir, E. B., 15 Oct 2024, In: Clinical Cancer Research. 30, 20, p. 4791-4799 9 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Results of the TARGET-TP Randomized Clinical Trial
Meirson, T., Gabizon, S. & Eizenstein, S., 18 Jul 2024, In: JAMA Oncology. 10, 7, p. 988 1 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Ribociclib plus Endocrine Therapy in Early Breast Cancer
Tannock, I. F., Meirson, T. & Fojo, A., 20 Jun 2024, In: New England Journal of Medicine. 390, 23, p. 2220-2221 2 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data
Meirson, T., Markel, G. & Goldstein, D. A., Dec 2024, In: BMC Gastroenterology. 24, 1, 414.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise
Mohyuddin, G. R. & Meirson, T., Nov 2023, In: Nature Reviews Clinical Oncology. 20, 11, p. 735-736 2 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis
Twafra, S., Sokolik, C. G., Sneh, T., Srikanth, K. D., Meirson, T., Genna, A., Chill, J. H. & Gil-Henn, H., 20 Jan 2023, In: Oncogene. 42, 4, p. 278-292 15 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Assessment of Median and Mean Survival Time in Cancer Clinical Trials
Das, A., Lin, T. A., Lin, C., Meirson, T., McCaw, Z. R., Tian, L. & Ludmir, E. B., Apr 2023, In: JAMA network open. 6, 4, e236498.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review
Hentzen, S., Meirson, T., Koehn, K., Goodman, A., Chakraborty, R., Sborov, D., Rubinstein, S. & Mohyuddin, G. R., Sep 2023, In: European Journal of Haematology. 111, 3, p. 491-498 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Correction: A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis (Oncogene, (2023), 42, 4, (278-292), 10.1038/s41388-022-02481-w)
Twafra, S., Sokolik, C. G., Sneh, T., Srikanth, K. D., Meirson, T., Genna, A., Chill, J. H. & Gil-Henn, H., 20 Jan 2023, In: Oncogene. 42, 4, p. 337 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People with Resected Renal Cancer?
Tannock, I. F., Goldstein, D. A., Ofer, J., Gyawali, B. & Meirson, T., 20 May 2023, In: Journal of Clinical Oncology. 41, 15, p. 2713-2717 5 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations -
Gender Gap in Leadership of Clinical Trials
Waldhorn, I., Bomze, D., Ben-Aharon, I., Schlosser, S., Markel, G., Ludmir, E. B. & Meirson, T., 4 Dec 2023, In: JAMA Internal Medicine. 183, 12, p. 1406-1408 3 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?
Nardone, V., Meirson, T., De Felice, F. & Meattini, I., 10 Aug 2023, In: Journal of Clinical Oncology. 41, 23, p. 3957-3958 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Sherry, A. D., Msaouel, P., McCaw, Z. R., Abi Jaoude, J., Hsu, E. J., Kouzy, R., Patel, R., Yang, Y., Lin, T. A., Taniguchi, C. M., Rödel, C., Fokas, E., Tang, C., Fuller, C. D., Minsky, B., Meirson, T., Sun, R. & Ludmir, E. B., Nov 2023, In: European Journal of Cancer. 194, 113357.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Projecting complete redaction of clinical trial protocols (RAPTURE): Redacted cross sectional study
Balaban, N., Mohyuddin, G. R., Kashi, A., Massarweh, A., Markel, G., Bomze, D., Goldstein, D. A. & Meirson, T., 14 Dec 2023, In: BMJ. 077329.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer
Meirson, T., Goldstein, D. A., Gyawali, B. & Tannock, I. F., Jun 2023, In: The Lancet Oncology. 24, 6, p. 589-593 5 p.Research output: Contribution to journal › Comment/debate
14 Scopus citations -
Systemic structural analysis of alterations reveals a common structural basis of driver mutations in cancer
Meirson, T., Bomze, D., Schueler-Furman, O., Stemmer, S. M. & Markel, G., 1 Mar 2023, In: NAR Cancer. 5, 1, zcac040.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells
Margolis, N., Moalem, H., Meirson, T., Galore-Haskel, G., Markovits, E., Baruch, E. N., Vizel, B., Yeffet, A., Kanterman-Rifman, J., Debby, A., Besser, M. J., Schachter, J. & Markel, G., Sep 2022, In: Cancer immunology research. 10, 9, p. 1127-1140 14 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
Meirson, T., Nardone, V., Pentimalli, F., Markel, G., Bomze, D., D’Apolito, M., Correale, P., Giordano, A., Pirtoli, L., Porta, C., Gray, S. G. & Mutti, L., Dec 2022, In: Journal of Translational Medicine. 20, 1, 593.Research output: Contribution to journal › Comment/debate
Open Access6 Scopus citations -
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma
Meirson, T., Neiman, V., Sternschuss, M., Markel, G. & Tannock, I. F., Nov 2022, In: The Lancet Oncology. 23, 11, p. e489Research output: Contribution to journal › Letter › peer-review
7 Scopus citations -
Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
Meirson, T., Pentimalli, F., Cerza, F., Baglio, G., Gray, S. G., Correale, P., Krstic-Demonacos, M., Markel, G., Giordano, A., Bomze, D. & Mutti, L., 9 Mar 2022, In: JAMA network open. 5, 3, e221490.Research output: Contribution to journal › Article › peer-review
Open Access40 Scopus citations -
Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy
Bomze, D., Mutti, L., Goldman, A., Markel, G. & Meirson, T., Jun 2022, In: The Lancet Oncology. 23, 6, p. e245Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Cytoreductive Surgery for Relapsed Ovarian Cancer
Meirson, T., Bomze, D. & Markel, G., 3 Mar 2022, In: New England Journal of Medicine. 386, 9, p. 896-897 2 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
For and Against Routine Removal of Peripheral Intravenous Catheters
Meirson, T., Goldman, A. & Bomze, D., Apr 2022, In: JAMA Internal Medicine. 182, 4, p. 455-456 2 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
Domovitz, T., Ayoub, S., Werbner, M., Alter, J., Tavor, L. I., Yahalom-Ronen, Y., Tikhonov, E., Meirson, T., Maman, Y., Paran, N., Israely, T., Dessau, M. & Gal-Tanamy, M., Nov 2022, In: Microbiology spectrum. 10, 6Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis
Bomze, D., Meirson, T., Hasan Ali, O., Goldman, A., Flatz, L. & Habot-Wilner, Z., 2022, In: Ocular Immunology and Inflammation. 30, 1, p. 191-197 7 p.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
Post-protocol therapy and informative censoring in the CANDOR study
Meirson, T., Markel, G., Prasad, V., Goodman, A. M. & Mohyuddin, G. R., Mar 2022, In: The Lancet Oncology. 23, 3, p. e97Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Radiographic progression-free survival in the ACIS trial for prostate cancer
Gilboa, S., Bomze, D., Markel, G. & Meirson, T., Jan 2022, In: The Lancet Oncology. 23, 1, p. e3Research output: Contribution to journal › Letter › peer-review
4 Scopus citations -
The common sense behind clinical trial names: An empirical study of trial acronyms
Meirson, T., Markel, G. & Bomze, D., 2022, In: Accountability in Research. 29, 7, p. 460-473 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Trends in Women’s Leadership of Oncology Clinical Trials
Waldhorn, I., Dekel, A., Morozov, A., Alon, E. S., Stave, D., Tsrooya, N. B., Schlosser, S., Markel, G., Bomze, D. & Meirson, T., 8 Jun 2022, In: Frontiers in Oncology. 12, 885275.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
2021
Assessment of robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect
Horesh, N., Bomze, D., Lim, C., Markel, G., Meirson, T. & Azoulay, D., 9 Jul 2021, In: Hepatobiliary Surgery and Nutrition. 10 p.Research output: Contribution to journal › Review article › peer-review
-
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports
Goldman, A., Bomze, D., Dankner, R., Hod, H., Meirson, T., Boursi, B. & Maor, E., Mar 2021, In: British Journal of Clinical Pharmacology. 87, 3, p. 1432-1442 11 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations -
Comment on "aLPPS Improves Survival Compared with TSH in Patients Affected of CRLM. Survival Analysis from the Randomized Controlled Trial LIGRO" by K. Hasselgren, et al., Annals of Surgery 2020 the Jury is Still out
Bomze, D., Markel, G., Meirson, T. & Azoulay, D., 1 Dec 2021, In: Annals of Surgery. 274, 6, p. E807-E809Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
Nissani, A., Lev-Ari, S., Meirson, T., Jacoby, E., Asher, N., Ben-Betzalel, G., Itzhaki, O., Shapira-Frommer, R., Schachter, J., Markel, G. & Besser, M. J., 14 May 2021, In: Journal for ImmunoTherapy of Cancer. 9, 5, e001743.Research output: Contribution to journal › Article › peer-review
45 Scopus citations -
Immunotherapy discontinuation in metastatic melanoma: Lessons from real-life clinical experience
Asher, N., Israeli-Weller, N., Shapira-Frommer, R., Ben-Betzalel, G., Schachter, J., Meirson, T. & Markel, G., 2 Jun 2021, In: Cancers. 13, 12, 3074.Research output: Contribution to journal › Article › peer-review
24 Scopus citations -
Informative censoring of surrogate end-point data in phase 3 oncology trials
Gilboa, S., Pras, Y., Mataraso, A., Bomze, D., Markel, G. & Meirson, T., Aug 2021, In: European Journal of Cancer. 153, p. 190-202 13 p.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
Sintilimab plus IBI305 for hepatocellular carcinoma
Bomze, D., Meirson, T. & Azoulay, D., Sep 2021, In: The Lancet Oncology. 22, 9, p. e386Research output: Contribution to journal › Letter › peer-review
-
Structural basis of SARS-CoV-2 spike protein induced by ACE2
Meirson, T., Bomze, D. & Markel, G., 1 Apr 2021, In: Bioinformatics. 37, 7, p. 929-936 8 p.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations -
The spectrum of multisystem inflammatory syndrome (MIS-C) in children infected with severe acute respiratory syndrome coronavirus 2
Amer, A., Ovadia, A., Meirson, G., Tasher, D. & Dalal, I., Jun 2021, In: Lymphosign Journal: the journal of inherited immune disorders. 8, 2, p. 48-54 7 p.Research output: Contribution to journal › Article › peer-review
-
2020
A helical lock and key model of polyproline II conformation with SH3
Meirson, T., Bomze, D., Kahlon, L., Gil-Henn, H. & Samson, A. O., 1 Jan 2020, In: Bioinformatics. 36, 1, p. 154-159 6 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Atezolizumab and bevacizumab in hepatocellular carcinoma
Bomze, D., Meirson, T. & Azoulay, D., 13 Aug 2020, In: New England Journal of Medicine. 383, 7, p. 693-694 2 p.Research output: Contribution to journal › Letter › peer-review
5 Scopus citations